— Know what they know.
Not Investment Advice
Also trades as: 2877.HK (HKSE) · $vol 1M · CSWYF (OTC) · $vol 0M

CSWYY OTC

China Shineway Pharmaceutical Group Limited
1W: +13.1% 1M: +26.9% 3M: +11.6% YTD: +11.6% 1Y: +11.6% 3Y: +26.6% 5Y: +20.1%
$21.49
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 65 · $40.6M mcap · 636283 float · 0.0041% daily turnover · Short 84% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$40.6M
52W Range18.16-22.23
Volume1
Avg Volume26
Beta0.72
Dividend$1.42
Analyst Ratings
No analyst coverage
Company Info
CEOZhenjiang Li
Employees2,822
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2012-02-14
Luan Cheng District
Shijiazhuang, HE 051430
CN
86 31 1880 30066
About China Shineway Pharmaceutical Group Limited

As an investment holding company, China Shineway Pharmaceutical Group Limited primarily focuses on the research, development, production, and commercialization of traditional Chinese medicines across mainland China and Hong Kong. Its product portfolio encompasses contemporary Chinese medicines delivered as soft capsules, granules, and injectable solutions. Additionally, it provides specialized TCM Formula Granules, addressing a broad spectrum of medical conditions such as cardiovascular and cerebrovascular issues, viral infections, orthopedic complaints, pediatric ailments, gynecological disorders, and gastrointestinal problems. Beyond pharmaceuticals, the group also engages in the trading of agricultural commodities. Established in 2004, China Shineway Pharmaceutical Group Limited maintains its corporate headquarters in Shijiazhuang, within the People's Republic of China. The company operates as a subsidiary under the umbrella of Forway Investment Limited.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms